4/17
08:20 am
crmd
Investors in CorMedix (NASDAQ:CRMD) have seen decent returns of 81% over the past five years [Yahoo! Finance]
Low
Report
Investors in CorMedix (NASDAQ:CRMD) have seen decent returns of 81% over the past five years [Yahoo! Finance]
4/9
08:10 am
crmd
CorMedix Inc. (NASDAQ: CRMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Medium
Report
CorMedix Inc. (NASDAQ: CRMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
4/8
10:41 am
crmd
CorMedix Inc. (NASDAQ: CRMD) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
Medium
Report
CorMedix Inc. (NASDAQ: CRMD) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
4/8
07:41 am
crmd
Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance [Yahoo! Finance]
Medium
Report
Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance [Yahoo! Finance]
4/8
07:30 am
crmd
Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance
Medium
Report
Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance
4/2
08:30 am
crmd
CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
Medium
Report
CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
4/1
02:28 pm
crmd
CorMedix Inc. (NASDAQ: CRMD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
CorMedix Inc. (NASDAQ: CRMD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/27
09:00 pm
crmd
CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is Investigating CorMedix Inc. on Behalf of CorMedix Stockholders and Encourages Investors to Contact the Firm
Low
Report
CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is Investigating CorMedix Inc. on Behalf of CorMedix Stockholders and Encourages Investors to Contact the Firm
3/27
01:12 am
crmd
CorMedix (CRMD) Q4 2024 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
CorMedix (CRMD) Q4 2024 Earnings Call Transcript [Yahoo! Finance]
3/26
06:00 pm
crmd
Kirby McInerney LLP Announces Investigation Against CorMedix Inc. (CRMD) on Behalf of Investors
Medium
Report
Kirby McInerney LLP Announces Investigation Against CorMedix Inc. (CRMD) on Behalf of Investors
3/26
11:15 am
crmd
CorMedix Inc. (NASDAQ: CRMD) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $12.00 price target on the stock.
Low
Report
CorMedix Inc. (NASDAQ: CRMD) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $12.00 price target on the stock.
3/26
08:19 am
crmd
CorMedix Inc. (NASDAQ: CRMD) had its price target lowered by analysts at Needham & Company LLC from $18.00 to $12.00. They now have a "buy" rating on the stock.
Medium
Report
CorMedix Inc. (NASDAQ: CRMD) had its price target lowered by analysts at Needham & Company LLC from $18.00 to $12.00. They now have a "buy" rating on the stock.
3/25
05:06 pm
crmd
INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer & Holzer, LLC
Medium
Report
INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer & Holzer, LLC
3/25
09:07 am
crmd
CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
3/25
09:05 am
crmd
CorMedix Inc. (NASDAQ: CRMD) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
High
Report
CorMedix Inc. (NASDAQ: CRMD) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
3/25
07:30 am
crmd
CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
High
Report
CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
3/18
08:30 am
crmd
CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025
Low
Report
CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025
3/8
05:34 am
crmd
CorMedix Inc. (NASDAQ: CRMD) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Low
Report
CorMedix Inc. (NASDAQ: CRMD) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
3/7
07:25 am
crmd
CorMedix Inc. (NASDAQ: CRMD) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $18.00 price target on the stock.
Medium
Report
CorMedix Inc. (NASDAQ: CRMD) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $18.00 price target on the stock.
3/5
08:11 am
crmd
CorMedix Inc. (NASDAQ: CRMD) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
Medium
Report
CorMedix Inc. (NASDAQ: CRMD) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
3/3
09:53 am
crmd
Kidney Community Comes Together for American Kidney Fund's Sixth Annual Kidney Action Week® [Yahoo! Finance]
Medium
Report
Kidney Community Comes Together for American Kidney Fund's Sixth Annual Kidney Action Week® [Yahoo! Finance]
1/22
08:21 am
crmd
CorMedix Inc. (NASDAQ: CRMD) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
Low
Report
CorMedix Inc. (NASDAQ: CRMD) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
1/21
08:00 am
crmd
CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities
Medium
Report
CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities